Skip to content

Apogee Therapeutics (APGE) IPO deck

Apogee Therapeutics, a biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and related inflammatory and immunology indications.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest